The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.85BCNY
727.65M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue (TTM)
501.95MCNY
75.24M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
-40.18%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Beta
0.8620x
vs all stocks
Updated Oct 21, 2026
52-Week Change
-29.56%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
4.85BCNY
727.65M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
3.73BCNY
558.38M · vs all stocks (USD)
Updated Oct 21, 2026
Forward P/E
20.99x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Price to Sales (TTM)
9.67x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Price to Book (MRQ)
2.96x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to Revenue
7.42x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Enterprise to EBITDA
-36.36x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 469×.Updated Oct 21, 2026
Gross Margin
29.65%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 27.53%.Updated Oct 21, 2026
Profit Margin
-40.18%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Margin
-27.49%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Assets (TTM)
-3.19%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Return on Equity (TTM)
-12.79%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Revenue (TTM)
501.95MCNY
75.24M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
2.42CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
61.60%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Gross Profit (TTM)
138.20MCNY
20.71M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
7.94MCNY
1.19M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
-201.69MCNY
-30.23M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
47.93%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
-7.92MCNY
-1.19M · vs all stocks (USD)
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.27%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Minority Interest (Equity)
16.18MCNYFY2025 · Dec 31, 2025
Revenue
439.09MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
302.87MCNYFY2025 · Dec 31, 2025
Gross Profit
136.22MCNYFY2025 · Dec 31, 2025
Operating Income
-70.31MCNY
-10.54M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-199.61MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.58MCNYFY2025 · Dec 31, 2025
Net Income
-198.03MCNYFY2025 · Dec 31, 2025
EBIT
-194.45MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
7.94MCNYFY2025 · Dec 31, 2025
Research & Development
29.80MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
47.52MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.99MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
10.39MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.15MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.8800CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.8800CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
202.38MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
202.38MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-198.03MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
19.94MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-195.36MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-220.14MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
640.47MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-198.03MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
11.11MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
51.88MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-60.31MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-24.78MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-644.50KCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.31BCNYFY2025 · Dec 31, 2025
Sale of Investments
2.07BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-876.07KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-264.74MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
10.33MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-354.29KCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-166.52KCNYFY2025 · Dec 31, 2025
Other Financing Charges
-40.97MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-31.16MCNYFY2025 · Dec 31, 2025
Shares Outstanding
228.99MSharesUpdated Oct 21, 2026
Float Shares
176.74MSharesUpdated Oct 21, 2026
% Held by Insiders
30.20%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
2.87%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
1.22BCNY
182.27M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
5.39CNYUpdated Oct 21, 2026
Total Debt (MRQ)
143.34MCNY
21.48M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.0881x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Current Ratio (MRQ)
3.25x
vs Scientific & Technical Instruments peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
7.16CNYUpdated Oct 21, 2026
Total Assets
2.35BCNY
351.51M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.72BCNYFY2025 · Dec 31, 2025
Total Liabilities
714.62MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
627.95MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
143.43MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
571.19MCNYFY2025 · Dec 31, 2025
Cash
639.44MCNYFY2025 · Dec 31, 2025
Cash Equivalents
32.38MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
671.82MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
616.35MCNYFY2025 · Dec 31, 2025
Accounts Receivable
68.25MCNYFY2025 · Dec 31, 2025
Inventory
288.89MCNYFY2025 · Dec 31, 2025
Accounts Payable
177.16MCNYFY2025 · Dec 31, 2025
Short-term Debt
44.46MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
28.07MCNYFY2025 · Dec 31, 2025
Long-term Debt
103.75MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
228.99MCNYFY2025 · Dec 31, 2025
Retained Earnings
93.01MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.63BCNY
244.40M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
40.09MCNYFY2025 · Dec 31, 2025
52-Week Low
14.34CNYUpdated Oct 21, 2026
52-Week High
36.79CNYUpdated Oct 21, 2026
52-Week Change
-29.56%
vs all stocks
Updated Oct 21, 2026
Beta
0.8620x
vs all stocks
Updated Oct 21, 2026
50-Day MA
22.59CNYUpdated Oct 21, 2026
200-Day MA
26.05CNYUpdated Oct 21, 2026
Avg 10-Day Volume
4.39MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
5.04MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
-1.00CNYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -27.5%, lower than 95% of its Scientific & Technical Instruments peers (median 9%)Significant